Top Markets
Coin of the day
Manzo Pharmaceuticals, Inc. Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO
Rang in Aktien #40587
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-12
Marktkapitalisierung
$115.95K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Manzo Pharmaceuticals, Inc. (MNZO)

Kategorie

EPS für Manzo Pharmaceuticals, Inc. (MNZO)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Manzo Pharmaceuticals, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Manzo Pharmaceuticals, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber